湖南师范大学学报（医学版）
湖南師範大學學報（醫學版）
호남사범대학학보（의학판）
JOURNAL OF HUNAN NORMAL UNIVERSITY(MEDICAL SCIENCE)
2014年
4期
56-58
,共3页
凌大军%石建%许利军%周江云%李铁军
凌大軍%石建%許利軍%週江雲%李鐵軍
릉대군%석건%허리군%주강운%리철군
多西紫杉醇联合消癌平注射液%二线治疗%晚期NSCLC%效果
多西紫杉醇聯閤消癌平註射液%二線治療%晚期NSCLC%效果
다서자삼순연합소암평주사액%이선치료%만기NSCLC%효과
Docetaxel plus Xiaoaiping injection%second-line treatment%advanced NSCLC%effect
目的：探讨多西紫杉醇联合消癌平注射液二线治疗晚期NSCLC的效果。方法：统计分析2012年1月至2014年1月我院肿瘤科收治的50例晚期NSCLC患者的临床资料。结果：观察组患者治疗的总有效率28％（7／25）明显比对照组12％（3／25）高；观察组患者的体能状况好转率36％（9／25）明显比对照组12％（3／25）高；观察组患者的白细胞降低、血小板降低、恶心呕吐、肝功能损害Ⅰ度、Ⅱ度、Ⅲ度、Ⅳ度总体发生率明显比对照组低。结论：多西紫杉醇联合消癌平注射液二线治疗晚期NSCLC的效果良好，值得推广。
目的：探討多西紫杉醇聯閤消癌平註射液二線治療晚期NSCLC的效果。方法：統計分析2012年1月至2014年1月我院腫瘤科收治的50例晚期NSCLC患者的臨床資料。結果：觀察組患者治療的總有效率28％（7／25）明顯比對照組12％（3／25）高；觀察組患者的體能狀況好轉率36％（9／25）明顯比對照組12％（3／25）高；觀察組患者的白細胞降低、血小闆降低、噁心嘔吐、肝功能損害Ⅰ度、Ⅱ度、Ⅲ度、Ⅳ度總體髮生率明顯比對照組低。結論：多西紫杉醇聯閤消癌平註射液二線治療晚期NSCLC的效果良好，值得推廣。
목적：탐토다서자삼순연합소암평주사액이선치료만기NSCLC적효과。방법：통계분석2012년1월지2014년1월아원종류과수치적50례만기NSCLC환자적림상자료。결과：관찰조환자치료적총유효솔28％（7／25）명현비대조조12％（3／25）고；관찰조환자적체능상황호전솔36％（9／25）명현비대조조12％（3／25）고；관찰조환자적백세포강저、혈소판강저、악심구토、간공능손해Ⅰ도、Ⅱ도、Ⅲ도、Ⅳ도총체발생솔명현비대조조저。결론：다서자삼순연합소암평주사액이선치료만기NSCLC적효과량호，치득추엄。
Objective To investigate the effectiveness of Docetaxel Injection Xiaoaiping joint second-line in the treatment of advanced NSCLC .Methods The clinical data of 50 cases of patients with advanced NSCLC trea-ted in our hospital oncology from January 2012 to January 2014 were statistically analyzed .Results The treatment total efficiency of the observation group 28%(7/25) was significantly higher than the control group 12%(3/25);The physical condition improvement rate of the observation group 36% ( 9/25 ) was significantly higher than the control group 12%(3/25);The overall incidence rates of leukopenia , thrombocytopenia , nausea, vomiting, liver damage ⅰdegree, degreeⅡ, degreeⅢ,ⅳdegree of the observation group were significantly lower than the con-trol.Conclusion The effectiveness of Docetaxel Injection Xiaoaiping joint second-line is good in the treatment of advanced NSCLC , so is worthy of promoting .
